vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $253.4M, roughly 1.1× Palomar Holdings, Inc.). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs -16.5%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.
HCM vs PLMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $253.4M |
| Net Profit | $2.0M | — |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 28.7% |
| Net Margin | 0.7% | — |
| Revenue YoY | -16.5% | 62.7% |
| Net Profit YoY | -83.6% | — |
| EPS (diluted) | $0.00 | $2.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $253.4M | ||
| Q3 25 | — | $244.7M | ||
| Q2 25 | $277.7M | $203.3M | ||
| Q1 25 | $324.5M | $174.6M | ||
| Q4 24 | — | $155.8M | ||
| Q3 24 | — | $148.5M | ||
| Q2 24 | $305.7M | $131.1M | ||
| Q1 24 | — | $118.5M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | — | $51.5M | ||
| Q2 25 | $455.0M | $46.5M | ||
| Q1 25 | $11.9M | $42.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $30.5M | ||
| Q2 24 | $25.8M | $25.7M | ||
| Q1 24 | — | $26.4M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | 28.7% | ||
| Q3 25 | — | 27.4% | ||
| Q2 25 | -1.3% | 29.5% | ||
| Q1 25 | -5.0% | 30.8% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.9% | ||
| Q2 24 | -9.0% | 25.5% | ||
| Q1 24 | — | 29.0% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | 163.8% | 22.9% | ||
| Q1 25 | 3.7% | 24.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 20.5% | ||
| Q2 24 | 8.4% | 19.6% | ||
| Q1 24 | — | 22.3% |
| Q4 25 | $0.00 | $2.05 | ||
| Q3 25 | — | $1.87 | ||
| Q2 25 | $0.52 | $1.68 | ||
| Q1 25 | $0.01 | $1.57 | ||
| Q4 24 | — | $1.29 | ||
| Q3 24 | — | $1.15 | ||
| Q2 24 | $0.03 | $1.00 | ||
| Q1 24 | — | $1.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $106.9M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $942.7M |
| Total Assets | $1.8B | $3.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $106.9M | ||
| Q3 25 | — | $111.7M | ||
| Q2 25 | $1.4B | $81.3M | ||
| Q1 25 | $836.1M | $119.3M | ||
| Q4 24 | — | $80.4M | ||
| Q3 24 | — | $86.5M | ||
| Q2 24 | $802.5M | $47.8M | ||
| Q1 24 | — | $61.4M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $942.7M | ||
| Q3 25 | — | $878.1M | ||
| Q2 25 | $1.2B | $847.2M | ||
| Q1 25 | $759.9M | $790.4M | ||
| Q4 24 | — | $729.0M | ||
| Q3 24 | — | $703.3M | ||
| Q2 24 | $740.1M | $532.6M | ||
| Q1 24 | — | $501.7M |
| Q4 25 | $1.8B | $3.1B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | $1.8B | $2.8B | ||
| Q1 25 | $1.3B | $2.4B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | — | $1.9B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $409.1M |
| Free Cash FlowOCF − Capex | $3.4M | $409.0M |
| FCF MarginFCF / Revenue | 1.2% | 161.4% |
| Capex IntensityCapex / Revenue | 1.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $700.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $409.1M | ||
| Q3 25 | — | $83.6M | ||
| Q2 25 | $-72.9M | $120.9M | ||
| Q1 25 | $40.3M | $87.2M | ||
| Q4 24 | — | $261.2M | ||
| Q3 24 | — | $100.3M | ||
| Q2 24 | $-39.8M | $55.1M | ||
| Q1 24 | — | $33.1M |
| Q4 25 | $3.4M | $409.0M | ||
| Q3 25 | — | $83.6M | ||
| Q2 25 | $-82.2M | $120.8M | ||
| Q1 25 | $32.5M | $87.1M | ||
| Q4 24 | — | $260.9M | ||
| Q3 24 | — | $100.1M | ||
| Q2 24 | $-49.9M | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.2% | 161.4% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | -29.6% | 59.4% | ||
| Q1 25 | 10.0% | 49.9% | ||
| Q4 24 | — | 167.5% | ||
| Q3 24 | — | 67.4% | ||
| Q2 24 | -16.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.4% | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 3.3% | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | -0.16× | 2.60× | ||
| Q1 25 | 3.38× | 2.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | -1.54× | 2.14× | ||
| Q1 24 | — | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
